Business Context and Reporting Period
This Form 8-K is filed by Oculus Innovative Sciences, Inc. (not Sonoma Pharmaceuticals, Inc.) on July 30, 2015. The filing serves to announce the company's financial results for the fiscal quarter ended June 30, 2015. The full details of these results are contained in a press release furnished as Exhibit 99.1, which is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached press release (Exhibit 99.1), the text of which is not included in the input.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms that results for the quarter ended June 30, 2015, were announced.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer regarding forward-looking statements. These statements express the company's intentions, beliefs, and expectations regarding future activities. The company notes that actual outcomes may differ materially due to risks, uncertainties, and assumptions, including those discussed in its Annual Report on Form 10-K. The company undertakes no obligation to update these statements after the date of this report.
Investor Verification Checklist
- Verify the correct registrant name is Oculus Innovative Sciences, Inc., as the input metadata incorrectly listed Sonoma Pharmaceuticals, Inc.
- Locate and review Exhibit 99.1 (the press release) to obtain specific financial figures for the quarter ended June 30, 2015.
- Review the company's most recent Form 10-K for a detailed discussion of risk factors referenced in the forward-looking statements.
- Confirm the filing date of July 30, 2015, aligns with the company's fiscal calendar for the second quarter.